Cargando…

Mineralization in a Critical Size Bone-Gap in Sheep Tibia Improved by a Chitosan-Calcium Phosphate-Based Composite as Compared to Predicate Device

Deacetylated chitin derivatives have been widely studied for tissue engineering purposes. This study aimed to compare the efficacy of an injectable product containing a 50% deacetylated chitin derivative (BoneReg-Inject™) and an existing product (chronOS Inject(®)) serving as a predicate device. A s...

Descripción completa

Detalles Bibliográficos
Autores principales: Örlygsson, Gissur, Laxdal, Elín H., Kárason, Sigurbergur, Dagbjartsson, Atli, Gunnarsson, Eggert, Ng, Chuen-How, Einarsson, Jón M., Gíslason, Jóhannes, Jónsson, Halldór
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836995/
https://www.ncbi.nlm.nih.gov/pubmed/35160784
http://dx.doi.org/10.3390/ma15030838
Descripción
Sumario:Deacetylated chitin derivatives have been widely studied for tissue engineering purposes. This study aimed to compare the efficacy of an injectable product containing a 50% deacetylated chitin derivative (BoneReg-Inject™) and an existing product (chronOS Inject(®)) serving as a predicate device. A sheep model with a critical size drill hole in the tibial plateau was used. Holes of 8 mm diameter and 30 mm length were drilled bilaterally into the proximal area of the tibia and BoneReg-Inject™ or chronOS Inject(®) were injected into the right leg holes. Comparison of resorption and bone formation in vivo was made by X-ray micro-CT and histological evaluation after a live phase of 12 weeks. Long-term effects of BoneReg-Inject™ were studied using a 13-month live period. Significant differences were observed in (1) amount of new bone within implant (p < 0.001), higher in BoneReg-Inject(TM), (2) signs of cartilage tissue (p = 0.003), more pronounced in BoneReg-Inject(TM), and (3) signs of fibrous tissue (p < 0.001), less pronounced in BoneReg-Inject(TM). Mineral content at 13 months postoperative was significantly higher than at 12 weeks (p < 0.001 and p < 0.05, for implant core and rim, respectively). The data demonstrate the potential of deacetylated chitin derivatives to stimulate bone formation.